Savić, J. (7006866907)J. (7006866907)SavićVaragić, V.M. (7006591279)V.M. (7006591279)VaragićProkić, Dj. (16208847300)Dj. (16208847300)ProkićVujnov, S. (6602571380)S. (6602571380)VujnovProstran, M. (7004009031)M. (7004009031)ProstranŽunić, G. (6701794224)G. (6701794224)ŽunićStanimirović, D. (57198126072)D. (57198126072)StanimirovićRastovac-Bogdanović, M. (6504450557)M. (6504450557)Rastovac-Bogdanović2025-06-122025-06-121991https://doi.org/10.1016/0300-9572(91)90078-Dhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0026073917&doi=10.1016%2f0300-9572%2891%2990078-D&partnerID=40&md5=53b66acb15a22606219baf311da9b339https://remedy.med.bg.ac.rs/handle/123456789/1844The intravenous injection of physostigmine (70 μg kg1) produces a life-saving effect in acute haemorrhagic shock in non-anaesthetized rabbits. This effect is most probably due to a transfer of tissue fluids into circulation. The crucial beneficial effect of physostigmine might be a decrease of the capillary hydrostatic pressure due to changes in pre- to postcapillary resistance ratio. Both lines of defence comprise a normalization of blood pressure and normalization of blood volume, thus saving the life of the animal. © 1991.Blood pressureCentral control of blood pressureHaemorrhagic shockPhysostigmine